Upload
wing-richards
View
22
Download
2
Embed Size (px)
DESCRIPTION
IS ULTRA-SHORT COLD ISCHEMIA THE KEY TO ISCHEMIC CHOLANGIOPATHY AVOIDANCE IN DCD-LT?. O Detry, A Deroover , S Cheham , H Ledinh , C Coimbra, E Decker, L Kohnen , MF Hans, J Joris , S Lauwick , A Kaba , J Delwaide , M Meurisse , P Honoré. University of Liege, CHU Liege, Belgium. - PowerPoint PPT Presentation
Citation preview
Donation after circulatory death (DCD) liver transplantation (LT) has been introduced to partially overcome the organ donor shortage
DCD LT has lower graft survival due to increase rates of primary non-function and graft loss due to ischemic cholangiopathy with difficult to treat non-anastomotic biliary strictures
Aim: Report the authors‘ experience in DCD-LT, with a short cold ischemia time and without upper limit age criteria
- Retrospective 10 years monocentric experience- Center-oriented allocation within the Eurotransplant organisation- No upper limit DCD donor age criteria - 70 consecutive DCD-LT- DCD in OR, with heparin and donor comfort therapy- Death on circulatory criteria- 5 min no-touch period
IS ULTRA-SHORT COLD ISCHEMIA THE KEY TO ISCHEMIC CHOLANGIOPATHY AVOIDANCE IN DCD-LT?
O Detry, A Deroover, S Cheham, H Ledinh, C Coimbra, E Decker, L Kohnen, MF Hans, J Joris, S Lauwick, A Kaba, J Delwaide, M Meurisse, P Honoré
University of Liege, CHU Liege, Belgium
Median n IQR
DONORS Age (years)DRI
592.1
44.7 – 701.8-2.5
RECIPIENTS Age (years)Lab MELD
58.515
51.7-6411-20
RECIPIENTS indication HCC on cirrhotic liverOther cancers
Cirrhosis without cancerReTx for HAT
266
362
PROCEDURESDWIT (min)
Withdrawal phase (min)Acirculatory phase
19.5119
16 – 247-15.58-10
CIT (min)Total ischemia
235.5292
200-285268-340
- DCD may be a valuable source of liver grafts- DWIT < 30 min & CIT < 5 hours may lead to a low rate of graft loss due to PNF and/or
ischemic cholangiopathy- With DWIT < 30 min & CIT < 5 hours, DCD donors > 60 years sould be considered to really
increase the cadaveric donor pool
Median/n/%
Peak AST (UI/L) 1,163 702-2,810
Peak total bili (mg/dL) 30.4 18.6-62.2
PNF (n) 0
HAT (n) 1
1 year graft survival 91.3%
3 year graft survival 77.7%
Graft loss HAT: 1, cancer: 8, MOF: 4, other: 2
Intrahepatic symptomatic NA stricture 0